Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2007
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291625 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis
11/06/2007US7291623 Compounds that interact with kinases
11/06/2007US7291622 Administering a 4-Amino-2-[1-(o-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinylcarbamate derivative, optionally mixed with an organic nitrate or NO donor or a cGMP inhibitor for treating sexual dysfunction
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291608 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
11/06/2007US7291344 Administering a botulinum toxin
11/06/2007US7291332 Inflammatory mediator antagonists
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2388564C Caspase inhibitor
11/06/2007CA2267322C Pde iv inhibiting 2-cyanoiminoimidazole derivatives
11/06/2007CA2266556C Nmda (n-methyl-d-aspartate) antagonists
11/06/2007CA2212129C A method of preparing mixed glucosamine salts
11/06/2007CA2170236C Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
11/01/2007WO2007124316A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007WO2007123936A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
11/01/2007WO2007123186A1 Pharmaceutical product
11/01/2007WO2007123010A1 Agent for improving bone metabolism
11/01/2007WO2007122981A1 COUMARIN COMPOUND CAPABLE OF INHIBITING INDUCIBLE NITROGEN MONOOXIDE SYNTHASE (iNOS)
11/01/2007WO2007122885A1 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
11/01/2007WO2007122823A1 Tumor target cell capable of producing vector
11/01/2007WO2007122815A1 Bivalent antibody directed against bir1
11/01/2007WO2007122156A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
11/01/2007WO2007121976A1 Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
11/01/2007WO2007121924A2 Bisadenosine compounds as adenosine a2a receptor agonists
11/01/2007WO2007121923A1 Purine derivatives as a2a receptor agonists
11/01/2007WO2007121921A2 Purine derivatives for use as adenosin a2a receptor agonists
11/01/2007WO2007121919A1 Purine derivatives with activity to the adenosine a2a receptor
11/01/2007WO2007121918A2 Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine a2a receptor agonists
11/01/2007WO2007121917A2 Purine derivatives as adenosine receptor activator
11/01/2007WO2007121662A1 Diphenyl urea derivatives as kinase inhibitors, compositions and uses thereof
11/01/2007WO2007106022A3 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof.
11/01/2007WO2007103727A3 Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kb
11/01/2007WO2007093519A3 Ibandronate regimen for treating metastatic bone pain
11/01/2007WO2007085021A3 Methods of treating or preventing peritonitis with oxidative reductive potential water solution
11/01/2007WO2007072503A3 Combinations for managing inflammation and associated disorders
11/01/2007WO2007068815A3 Heterocyclic derivatives, preparation and therapeutic use thereof
11/01/2007WO2007059905A9 Thienopyrimidines treating inflammatory diseases
11/01/2007WO2007059515A3 Compositions of lipoxygenase inhibitors
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070255063 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
11/01/2007US20070254962 Methods of administering anti-inflammatory cyclooxygenase-2 selective inhibitors
11/01/2007US20070254909 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same
11/01/2007US20070254908 7-azaindoles, pharmaceutical compositions and their therapeutic applications
11/01/2007US20070254902 Methods and compositions utilizing quinazolinones
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007US20070254363 Substituted biaryl compounds for inflammation and immune-related uses
11/01/2007US20070253902 Treatment for inflammatory bowel disease
11/01/2007CA2649736A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007CA2649628A1 Pharmaceutical product
11/01/2007CA2649543A1 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
11/01/2007CA2649215A1 2,6,9-trisubstituted purine compounds as adenosine aza receptor modulators
11/01/2007CA2649211A1 Organic compounds
11/01/2007CA2649205A1 Organic compounds
11/01/2007CA2649029A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
11/01/2007CA2648813A1 Organic compounds
11/01/2007CA2648810A1 Organic compounds
11/01/2007CA2648741A1 Purine derivatives as a2a receptor agonists
11/01/2007CA2648037A1 Organic compounds
11/01/2007CA2644425A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
11/01/2007CA2641139A1 Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
10/2007
10/31/2007EP1849801A1 Tyrosine-based motif and clostridial neurotoxins
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1849479A1 Ameliorating agent for symptoms resulting from joint diseases
10/31/2007EP1849478A2 Inflammatory mediator antagonists
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1848743A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
10/31/2007EP1848719A1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
10/31/2007EP1848714A2 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
10/31/2007EP1848704A1 Novel tubulin polymerisation inhibitors
10/31/2007EP1848463A2 Method of conjugating aminothiol containing molecules to vehicles
10/31/2007EP1848435A2 Compounds for inflammation and immune-related uses
10/31/2007EP1848432A1 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
10/31/2007EP1848270A2 Transmucosal administration of drug compositions for treating and preventing disorders in animals
10/31/2007EP1755606B1 Quinazolinone derivatives useful as vanilloid antagonists
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1470143B1 Compounds that inhibit factor xa activity
10/31/2007EP1448198B1 Nicotin-or isonicotin benzothiazole derivatives
10/31/2007EP1420801B1 Use of fucans in the treatment of adhesions, arthritis and psoriasis
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1259626B1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
10/31/2007EP1192247B9 Sphingosine kinase enzyme
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1153013B1 5-ht1f agonists
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007DE102006019597A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
10/31/2007DE102006011574A1 Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln Substituted imidazo [2,1-b] thiazole compounds and their use for the preparation of medicaments
10/31/2007CN200966773Y Osteoproliferation plaster for reducing pain
10/31/2007CN101065375A Compounds, compositions containing them, preparations thereof and uses thereof
10/31/2007CN101065374A Substituted dipiperidine ccr2 antagonists
10/31/2007CN101062906A Agmatine sulfate hydrate and usage for drug rehabilitation, antiphlogistic, hypoglycemic and agmatine metabolism abnormality induced disease
10/31/2007CN101062393A Pill for invigorating blood circulation analgesia
10/31/2007CN101062387A Fang-feng bupleurum root decoction
10/31/2007CN101062377A Adhesive plaster for diminishing inflammation, expelling wind and cold and so on and its preparation method
10/31/2007CN101062366A Prescription for treating the pain of waist and leg
10/31/2007CN101062350A Chinese traditional medicine agent for treating wind-heat type common cold
10/31/2007CN101062320A Chinese traditional medical ointment for diminishing inflammation
1 ... 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 ... 1272